Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for your insight. Carry on mate. Smh
AMBS. Loading zone.
We are in 2013 wake up. Different animal. And you really are tough with your caps. I'm shaking.
Look up GDNF and MANF. Do it. Check it. And then get back to me about AMBS and its future
Why strange? AMBS Gerald believed in his fathers discovery. And so does Dr. Rubinfeld? Gerald used his own cash to buy the patents. Smart investment for its multiple application possibilities Strange , i think not.
AMBS submits IND's & orphan designations that then get approved to proceed and the Venture capital rains upon them. you need not to worry. or if you want worry.. I'm not.
and they have plenty of funding to submit these applications.
have a wonderful day
GL2ALL
FYI The swiss firm performing the audit on the MANF results is also helping AMBS prepare their IND package
AMBS will be filing MANF IND's for Orphan Indications, lets not forget that this is what Dr. Rubinfeld stated as their plan to get MANF to market sooner at the Biotech Showcase in his closing statements.
PPS moves!!!! on Orphan Designation Apps, IND Filings .. and really moves on Approvals. Sooner rather than later for Action IMO..
http://ir.stockpr.com/amarantus/company-news/detail/273/amarantus-biosciences-explores-orphan-drug-strategy-based-on-manf-protein-folding
A prime example of a successful strategy is Genzyme, who was successful in turning its orphan drug strategy into a $20.1Bbuyout by Sanofi Aventis in 2011. Another example of a successful orphan strategy is FerroKin Biosciences, who was successfully acquired by Shire for $325M in early 2012 with only $27M in paid-in-capital and a virtual staff of 7 employees. In 2011, Alexion Pharmaceuticals reported $783M in revenue based on sales of its only product Soliris, a drug that treats a population of approximately 10,000 patients in the US and Western Europe.
"When you get orphan status designation, you go up on our website saying that the FDA has given a nod that this is promising for this rare disease," said Cote. "And then the venture capital rains down from the heavens. That is how it has tended to work for a lot of these companies."
PS.. you do not need to be in Human Clinical Trials to get bought out or close a JV Deal.
http://minnesota.publicradio.org/display/web/2010/08/05/orphan-drugs
I know this but its free advertising MJFF + AMBS ... and free money who turns that down?
AMBS
Jason Napodano keeps mentioning AMBS
via twitter 3/19
Jason Napodano, CFA @JNapodano
Addex awarded $1M grant from Michael J Fox. Be on the lookout for other MJFF grant winners over the next week or two. $AD-- $AMBS?
<blockquote class="twitter-tweet"><p>Addex awarded $1M grant from Michael J Fox. Be on the lookout for other MJFF grant winners over the next week or two. <a href="https://twitter.com/search/$ADXN">$ADXN</a> <a href="https://twitter.com/search/$AMBS">$AMBS</a>?</p>— Jason Napodano, CFA (@JNapodano) <a href="https://twitter.com/JNapodano/status/313969714663669760">March 19, 2013</a></blockquote>
<script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script>
thanks for the post Doc.. I'm not so sure how BH will take this post.
AMBS does have a bright future ahead.. I do think we will see action sooner than later..
GL2ALL OF US THAT ARE ACTUALLY INVESTORS IN AMBS
Once again you leave out the important conclusion of my post
what this shows is that those 3 Pharma's and MJFF"s stategy with alpha-synuclein levels... has been met by Snags... again why this is a plus for AMBS & MANF since Amarantus Strategy is for MANF to focus on restoring the DA "Dopamine" levels. and these results that MANF has achieved are being audited as i type this.
Parkinson’s Patients May Be Harmed by Novel Treatment
I think this will help turn heads towards AMBS & MANF's future
http://www.bloomberg.com/news/2013-03-21/parkinson-s-patients-may-be-harmed-by-novel-treatment.html
From AMBS Twitter feed:
Let me show you, AMBS JV to finish revenue generating Blood tests. Pharma JV or buyout for MANF. TBI / MANF research grants. Government and pro sports funded. There are a number of alternatives.
Private company AMBS bought shell to go public
http://en.m.wikipedia.org/wiki/Alternative_public_offering#mw-mf-search
AMBS
End of May Target of .05 for VOIS
Welcome
Closer than you think.. AMBS is... in my Yoda voice
also don't forget that the CEO of AMBS is delivering in what he says.. point in case De-listing from BBSE
he also said this:
“We just completed our first institutional capital raise and have attracted Big Pharma talent to our Advisory Board. We have data coming shortly on our MANF Parkinson’s program and expect additional corporate milestones will be reached in the coming weeks. As we achieve these milestones, we believe we will be in a good position to up-list to a national exchange.”
I see it a little different, not tired at all. I am just using this as an AMBS loading zone. I'm flipping other stocks and investing profits into this adding to my core position.
It is worth it, don't let this be the one that you have to say to yourself "why did I get out of this one."
AMBS LONG
GL2ALL
Excellent AMBS post once again.
Patience is the key here,, weak hands are getting weaker.
Strong hands will be rewarded.
AMBS LONG
Got some .0006's PCFG. Im happy. Golden here. Hello all
The sources that gave my the forecast for VOIS are personal and discretion does not allow me to reveal names . But one is in the tech industry and the other is a writer for a electronics mag.
I will continue to add at these levels. We wont be below a penny for long.
Received emails from 2 different sources. Price target for VOIS is .05 by end of May. Thats 2000% gain from here.
Bought 750k more
Strategic Buyers
Vois Grabs Mind Technologies
Mind Technologies develops software that allows users to interact with computers through a wireless, brainwave-detecting headset
http://www.themiddlemarket.com/news/vois-grabs-mind-technologies-238104-1.html
picked up 500K today... shopping for more tomorrow
when the deal is announced the will gain 500% in less than 30 Minutes..
Yeah. I have heard from 3 different groups that have told me they are accumulating VOIS. I imagine yesterday was most of them. I expect this to launch soon.
GL2us
Nice follow up. AMBS.
AMBS stickies. ? MODS whats going on. This should be a big couple weeks. Can you restore the AMBS DD Stickies?
AMBS PPS is telling me this is a loading point and there is still manipulating going on with this stocks price.
I have been loading still so i can't complain..
Maybe you should not fight the speculation on this board soo much as you do and maybe we can see a little increase in PPS prior to PR's ( this is a joke btw )
I feel more confident in the Stock after our groups meeting with the CEO of AMBS
I think we all have increased our positions..
GL2ALL
quite the AMBS speculator now..
and in a negative way too. how funny it seems to me that how Righteous you portray yourself to be you would say a comment like I hope the possibilities are not baked into the current PPS.. what gives? so you are saying if they announce the JV with Banyan on Monday PPS will stay here? or when they sell rights to MANF to AMGEN PPS will not respond? for someone who likes to keep it real to say this, leads me to believe that you are just what I have thought all along and I don't need to say what that is. but its a Class A rank
GL2U
and none of your possibilities invalidate the possibilities I have raised. after all you were the one talking about only some of the possibilities right and for the first time that I recall right? i found it odd.. so i had to reply.. just keeping it even
GL2U..
AMBS LONG
i have sent AMBS CEO 5 emails and all have been answered, maybe you don't have his personal email. but then again I don't know what you wrote asking him.
try calling him.. I think its worth it since you have a nice investment in the company. don't give up after 1 try he may have some phone calls from Switzerland he is waiting for and or some JV's or Buyouts he is dealing with..
GL2U
you are talking about AMBS possibilities now?
lets see:
JV with BIG PHARMA for Orphan Indications for MANF
JV Partnership with Bayan Biomarkers to complete clinical testing and market Biomarkers Blood test for various indications. including TBI
Buyout from Big Pharma once MANF data has been validated by Swiss firm
Phenoguard Protein Discovery Engine finds an even better molecule
yes anything is still possible.. for AMBS we all shall wait and see who is in and who is out.
GL2ALL
we went over this already...AMBS TA is not gagged... it's the T/A's policy not to disclose any info on behalf of ALL of its clients.
Actual proof. Vs Hearsay. Ruling in favor of. ........
Have a nice night. AMBS.
Create doubt. I will continue to buy from the weak hands. Thanks
You should not edit the actual quote
SMH
AMBS
Yes i agree you are wrong. Its TA's policy. The CEO clearly states it
AMBS
AMBS
I only lie while i sleep:
"
I am sorry, but it is our policy to not provide public disclosure on behalf of our clients.
"
Yoel Goldfeder, Esq.
Chief Executive Officer
VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, New York 11516
Phone: (212) 828-8436
Mobile: (646) 599-1296
Facsimile: (646) 536-3179
www.VStockTransfer.com
**********************************************************************
Unless explicitly stated otherwise, the contents of this email and all attachments are not to be considered legal advice, nor are they intended to create an attorney/client relationship between sender and recipient.
This message and all attachments are a private communication and may be confidential or protected by privilege. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained in or attached to this message is strictly prohibited. Please notify the sender of the delivery error by replying to this message, and then delete it from your system. Thank you.
************************************************************************
-----Original Message-----
From: Zxxxxxxx c c c c.
Sent: Thursday, January 31, 2013 10:31 PM
To: info
Subject: AMBS
Hello Allison Niccols,
I hope you are doing well, Can you please inform me what is the current share structure is for: AMBS - Amarantus Bioscience
Thank you in advance
Best Regards,
Funny i spoke to TA and they told me its was their policy not to give out Share Structure information.
Not for AMBS not for any company they work for. I have the e-mail still gotta look for it. But if i were you you should call them again or really contact them and clear that up for yourself.
And their are also TA's that have a policy to not give out share structure info. For all the companies they service. As is the case with AMBS's TA.
Send Gerald an email. He usually responds. He does to me
I added more shares today. AGain.
BUYINS.NET Updates Amarantus BioSciences SqueezeTrigger Report
http://ih.advfn.com/p.php?pid=nmona&article=56730849&symbol=AMBS